Skip to main content
Log in

Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The cardioprotective property of hydrogen sulfide (H2S) is recently reported. However, cellular signaling cascades mediated by H2S are largely unclear. This study was undertaken to explore the molecular mechanism of H2S-induced cardioprotection in mouse heart by utilizing in vivo model of cardiac injury. We report here that intraperitoneal administration of sodium hydrogen sulfide (NaHS, 50 μmol kg−1 day−1 for 2 days), a H2S donor, significantly (P ≤ 0.05) increased nitric oxide levels in serum as well as myocardium without any sign of myocardial injury. Typical characteristics of myocardial injury induced by isoproterenol (ISO) administration was significantly (P ≤ 0.05) abrogated by NaHS administration as evidenced from reduction in elevated thiobarbituric acid reactive substances (TBARS) and normalization of glutathione (GSH), glutathione peroxidase, superoxide dismutase (SOD), and catalase activity. Further, decrease in TNF-α expression and improvement in myocardial architecture was also observed. However, co-administration of N-nitro-l-arginine methyl ester, a nitric oxide synthase (NOS) inhibitor, and Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor along with NaHS and ISO abrogated the beneficial effect of H2S differentially. Inhibition of NOS significantly (P ≤ 0.05) increased serum creatine kinase, lactate dehydrogenase, serum glutamic oxaloacetic transaminase activity and myocardial TBARS, along with significant (P ≤ 0.05) reduction of myocardial GSH, SOD, and catalase. This was followed by increase in TNF-α expression and histopathological changes. Our results revealed that H2S provides myocardial protection through interaction with NOS and COX-2 pathway and inhibition of NOS completely abrogates the hydrogen sulfide-induced cardioprotection in mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Li L, Moore PK (2008) Putative biological roles of hydrogen sulfide in health and disease: a breath of not so fresh air? Trends Pharmacol Sci 29:84–90

    Article  PubMed  Google Scholar 

  2. Hui Y, Junbao D, Chaoshu T (2004) The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertention in rats. Biochem Biophys Res Commun 313:22–27

    Article  Google Scholar 

  3. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, Tang C (2004) H2S generated by heart in rat and it’s effects on cardiac function. Biochem Biophys Res Commun 313:362–368

    Article  PubMed  CAS  Google Scholar 

  4. Li L, Bhatia M, Moore PK (2006) Hydrogen sulphide—a novel mediator of inflammation? Curr Opin Pharmacol 6:125–129

    Article  PubMed  CAS  Google Scholar 

  5. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, Moore PK (2006) Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 316:670–678

    Article  PubMed  CAS  Google Scholar 

  6. Pan TT, Feng ZN, Lee SW, Moore PK, Bian JS (2006) Endogenous hydrogensulfide contributes to the cardioprotection by metabolic inhibition preconditioning in the rat ventricular myocytes. J Mol Cell Cardiol 40(1):119–130

    Article  PubMed  CAS  Google Scholar 

  7. Johansen D, Ytrehus K, Baxter GF (2006) Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury—evidence for a role of K ATP channels. Basic Res Cardiol 101(1):53–60

    Article  PubMed  CAS  Google Scholar 

  8. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, Jiao X, Scalia R, Kiss L, Szabo C, Kimura H, Chow CW, Lefer DJ (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci 104(39):15560–15565

    Article  PubMed  CAS  Google Scholar 

  9. Minamishima S, Bougaki M, Sips PY, Yu JD, Minamishima YA, Elrod JW, Lefer DJ, Bloch KD, Ichinose F (2009) Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice. Circulation 120(10):888–896

    Article  PubMed  CAS  Google Scholar 

  10. Hu L, Pan T, Neo KL, Yong QC, Bian J (2008) Cyclooxygenase-2 mediates the delayed cardioprotection induced by hydrogen sulfide preconditioning in isolated rat cardiomyocytes. Eur J Physiol 455:971–978

    Article  CAS  Google Scholar 

  11. Bolli R (2000) The late phase of preconditioning. Circ Res 87(11):972–983

    PubMed  CAS  Google Scholar 

  12. Sato H, Bolli R, Rokosh GD, Bi Q, Dai S, Shirk G, Tang XL (2007) The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2 mediated mechanism in conscious rats. Am J Physiol 293(4):H2557–H2564

    CAS  Google Scholar 

  13. Pacher P, Liaudet L, Bai P, Mabley JG, Kaminski PM, Virag L, Deb A, Szabo E, Ungvari Z, Wolin MS (2003) Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin induced cardiac dysfunction. Circulation 107(6):896–904

    Article  PubMed  CAS  Google Scholar 

  14. Chattopadhyay A, Biswas S, Bandyopadhyay D, Sarkar C, Datta AG (2003) Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. Mol Cell Biochem 245:43–49

    Article  PubMed  CAS  Google Scholar 

  15. Annadora J, Michel B (1995) Oxygen free radicals in rat limbic structures after kainite induced seizurs. Free Radic Biol Med 18:993–1002

    Article  Google Scholar 

  16. Abd El-Gawad HM, El-Sawalhi (2004) Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicine: role of aminoguanidine. J Biochem Mol Toxicol 18(2):69–77

    Article  PubMed  CAS  Google Scholar 

  17. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC (2007) The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovas Res 26(1):29–40

    Article  Google Scholar 

  18. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358

    Article  PubMed  CAS  Google Scholar 

  19. Zhao G, Al-Mehdi AB, Fisher AB (1997) Anoxia-reoxygenation versus ischemia in isolated rat lungs. Am J Physiol Lung Cellular Mol Physiol 273(6 pt 1):1112–1117

    Google Scholar 

  20. Aebi H (1984) Catalase in vitro. Method Enzymol 105:121–126

    Article  CAS  Google Scholar 

  21. Ellman GL (1959) Tissue sulfhydryl groups biophysics. Arch Biochem 82:70–77

    Article  PubMed  CAS  Google Scholar 

  22. Wendel A (1981) Glutathione peroxidase. Method Enzymol 77:325–333

    Article  CAS  Google Scholar 

  23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  24. Banerjee SK, McGaffin KR, Pastor-Soler NM, Ahmad F (2009) SGLT-1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovas Res 84:111–118

    Article  CAS  Google Scholar 

  25. Mukherjee S, Chen LY, Papadimos TJ, Huang S, Zuraw BL, Pan ZK (2009) Lipopolysaccharide-driven through cytokine production in macrophages is regulated by both Myd88 and TRAM. J Biol Chem 284:29391–29398

    Article  PubMed  CAS  Google Scholar 

  26. Cardounel AJ, Julian D, Predmore BL (2011) Hydrogen sulfide increases nitric oxide production from endothelial cells by an Akt-dependent mechanism. Front Oxidant Physiol (in press). http://www.frontiersin.org/oxidant_physiology/abstract/9722

  27. Karthick M, Prince SM (2006) Preventive effect of rutin, a bioflavonoid on lipid peroxides and antioxidants in isoproterenol induced myocardial infarction in rats. J Pharm Pharmacol 58:701–707

    Article  PubMed  CAS  Google Scholar 

  28. Warenycia MW, Goodwin LR, Benishin CG, Reiffenstein RJ, Francom DM, Taylor JD, Dieken FP (1989) Acute hydrogen sulfide poisoning: demonstration of elective uptake of sulfide by the brainstem by measurement of brain sulphide levels. Biochem Pharmacol 38:973–981

    Article  PubMed  CAS  Google Scholar 

  29. Collins P, Billings CG, Barer GR, Daly JJ, Jolly A (1975) Quantitation of isoprenaline-induced changes in the ventricular myocardium. Cardiovasc Res 9:797–806

    Article  PubMed  CAS  Google Scholar 

  30. Sivarajah A, Collino M, Yasin M, Benetti E, Gallicchio M, Mazzon E, Cuzzocrea S, Fantozzi R, Thiemermann C (2009) Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock 31(3):267–274

    Article  PubMed  CAS  Google Scholar 

  31. Martin M, Meyer-Kirchrath J, Kaber G, Jacoby C, Flogel U, Schrader J, Ruther U, Schror K, Hohlfeld T (2005) Cardiospecific overexpression of the prostaglandin EP3 receptor attenuates ischemia-induced myocardial injury. Circulation 112(3):400–406

    Article  PubMed  CAS  Google Scholar 

  32. Smalling RW, Feld S, Ramanna N, Amirian J, Felli P, Vaughn WK, Swenson C, Janoff A (1995) Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction reperfusion model. Circulation 92(4):935–943

    PubMed  CAS  Google Scholar 

  33. Suchalatha S, Shyamala D (2004) Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian J Exp Biol 42:174–178

    PubMed  CAS  Google Scholar 

  34. Dhalla AK, Hill MF, Singal PK (1996) Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 28:506–514

    Article  PubMed  CAS  Google Scholar 

  35. Ji LL, Stratman FW, Lardy HA (1988) Antioxidant enzyme systems in rat liver and skeletal muscle Influences of selenium deficiency, chronic training, and acute exercise. Arch Biochem Biophys 263:150–160

    Article  PubMed  CAS  Google Scholar 

  36. Padmanabhan M, Mainzen Prince PS (2007) S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes. Life Sci 80:972–978

    Google Scholar 

  37. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, Du J, Tang C (2004) Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophy Res Commun 318:756–763

    Article  CAS  Google Scholar 

  38. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288(2):H971–H976

    Article  PubMed  CAS  Google Scholar 

  39. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601–605

    Article  PubMed  CAS  Google Scholar 

  40. Marie EG, Veronique G (2004) Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. Mol Cancer 3:298–304

    Google Scholar 

Download references

Acknowledgments

Financial support was provided by Ramalingaswami Fellowship fund (SKB) from Department of Biotechnology (DBT), Senior Research Fellowship (AK) from Council of Scientific and Industrial Research (CSIR), Government of India and IICT institute fund. We wish to thank Dr J S Yadav, Director, IICT, Hyderabad for providing all kind of support for this study and gratefully acknowledge Dr Rajkumar Banerjee for his suggestions and critical review of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sanjay Kumar Banerjee.

Additional information

Bhavesh Sojitra and Yogesh Bulani contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sojitra, B., Bulani, Y., Putcha, U.K. et al. Nitric oxide synthase inhibition abrogates hydrogen sulfide-induced cardioprotection in mice. Mol Cell Biochem 360, 61–69 (2012). https://doi.org/10.1007/s11010-011-1044-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-1044-6

Keywords

Navigation